I think every pot stock on asx does not have enough sales to pay...

I think every pot stock on asx does not have enough sales to pay for its research activities.
Some pot stocks have no income now nor in the immediate future yet are valued at 400million$ (with no federal license to sell cannabis either). Medlab is now below 100million$ value with a federal license to sell.
Study for Nanabidial to commence end of this month (18 parts cbd to 1 part thc) from real cannabis profile (not hemp). This is another exciting Medlab product to keep an eye out for in the not too distant future.

MDC is now close to 50% discount on the placement that raised 23million$.
I am keeping my fingers crossed the share price drifts between 38c-45c whilst the company is quiet. No one has been able to buy MDC this cheap in near 2 years! despite all the advancements the company has made in the medical marijuana arena. Especially in Australia, and listed on ASX.

It will be interesting to see if they push MDC down any further while the market is in shock and confusion.
GL